fluphenazine depot has been researched along with Delusional Disorder in 17 studies
fluphenazine decanoate : The prodrug of fluphenazine, an antipsychotic drug used for the symptomatic management of psychosis in patients with schizophrenia.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
Excerpt | Relevance | Reference |
---|---|---|
"A mild form of neuroleptic malignant syndrome (NMS) in a schizophrenic patient who was receiving a depot neuroleptic is described and beneficial response to oral diazepam 50 mg daily is reported." | 7.67 | Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP, 1988) |
"A mild form of neuroleptic malignant syndrome (NMS) in a schizophrenic patient who was receiving a depot neuroleptic is described and beneficial response to oral diazepam 50 mg daily is reported." | 3.67 | Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam. ( Christodoulou, GN; Havaki-Kontaxaki, BJ; Kontaxakis, VP; Markidis, MP, 1988) |
"Schizophrenia is thought to be the psychiatric diagnosis the most frequently associated with TD." | 1.39 | [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. ( Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I, 2013) |
"A male patient with chronic paranoid schizophrenia developed delusions of substitution that were of abrupt onset and short duration." | 1.28 | Delusions of substitution and diabetes mellitus. ( Khanna, N; Khanna, R, 1991) |
" The mean dosage of the drug was 25-50 mg per 3-4 weeks." | 1.27 | [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary]. ( Abramova, LI; Gushanskiĭ, EL, 1986) |
"The results of treating 251 therapeutically resistant patients with paranoid schizophrenia by moditen-depo, its combination with other psychotic drugs or leponex was compared." | 1.26 | [Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex]. ( Aranovich, AG; Gamburg, AL; Kotel'kevich, IuN; Omorokov, BM; Rasniuk, VA, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (64.71) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Umino, M | 1 |
Kobayashi, R | 1 |
Nisijima, K | 1 |
Suda, S | 1 |
Sejil, I | 1 |
Oumaya, A | 1 |
Bouguerra, C | 1 |
Mehdi, F | 1 |
Bellaaj, R | 1 |
Gallali, S | 1 |
Miller, DD | 1 |
Gamburg, AL | 1 |
Aranovich, AG | 1 |
Kotel'kevich, IuN | 1 |
Omorokov, BM | 1 |
Rasniuk, VA | 1 |
Balon, R | 1 |
Kabesh, Ia | 1 |
Papezhova, G | 1 |
Bartels, M | 1 |
Riffel, B | 1 |
Stöhr, M | 1 |
Müller, P | 1 |
Waldmann, KD | 1 |
Neumann, J | 1 |
Gaby, N | 1 |
Lefkowitz, D | 1 |
Israel, JR | 1 |
Russell, N | 1 |
Landmark, J | 1 |
Merskey, H | 1 |
Turpin, T | 1 |
Harasko-van der Meer, C | 1 |
Brücke, T | 1 |
Wenger, S | 1 |
Fischer, P | 1 |
Deecke, L | 1 |
Podreka, I | 1 |
Durst, R | 1 |
Dorevitch, A | 1 |
Fraenkel, Y | 1 |
Khanna, R | 1 |
Khanna, N | 1 |
Carotti, P | 1 |
Merli, R | 1 |
Kontaxakis, VP | 1 |
Christodoulou, GN | 1 |
Markidis, MP | 1 |
Havaki-Kontaxaki, BJ | 1 |
Abramova, LI | 1 |
Gushanskiĭ, EL | 1 |
Cadieux, RJ | 1 |
Kales, JD | 1 |
Kales, A | 1 |
Biever, J | 1 |
Mann, LD | 1 |
17 other studies available for fluphenazine depot and Delusional Disorder
Article | Year |
---|---|
Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Female; Fluphenazine; Hip; Humans; Injections, | 2017 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Rel | 2013 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Fema | 2003 |
[Treatment of therapeutically resistant paranoid schizophrenic patients with Moditen-depot combined with other psychotropic drugs and Leponex].
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Delayed-Action Preparatio | 1980 |
[Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Double-Blind Method; Female; Fluphenazine; Humans; Mal | 1982 |
[Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Flupenth | 1982 |
[What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Administration Sch | 1983 |
[Clinical experience with depot neuroleptic treatment].
Topics: Female; Fluphenazine; Hallucinations; Humans; Male; Prognosis; Psychotic Disorders; Schizophrenia; S | 1984 |
Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Delayed-Action Preparations; Female; Fluphenazine; Follow-Up Studies; Humans | 1982 |
A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
Topics: Adult; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Fluspirilene; Humans; Ma | 1982 |
Two cases of long term dopamine D2 receptor blockade after depot neuroleptics.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Delayed-Action Preparations; Dopamine D2 Receptor Anta | 1993 |
Platelet dysfunction associated with clozapine therapy.
Topics: Amobarbital; Blood Cell Count; Clozapine; Delayed-Action Preparations; Diazepam; Drug Monitoring; Dr | 1993 |
Delusions of substitution and diabetes mellitus.
Topics: Blood Glucose; Capgras Syndrome; Delusions; Diabetes Mellitus, Type 2; Fluphenazine; Humans; Middle | 1991 |
[Considerations on the use of long-acting neuroleptics in a mental health center].
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Depression; Fluphenazine; | 1986 |
Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
Topics: Administration, Oral; Adult; Diazepam; Drug Therapy, Combination; Fluphenazine; Humans; Injections, | 1988 |
[Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
Topics: Adult; Affective Symptoms; Ambulatory Care; Antidepressive Agents; Drug Therapy, Combination; Female | 1986 |
Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report.
Topics: Adaptation, Psychological; Adult; Combined Modality Therapy; Dyskinesia, Drug-Induced; Fluphenazine; | 1985 |